J. Folkman
Molecular Biology · 2000–2008
A researcher in the Science corpus: 10 papers; trusts 11 researchers and is trusted by 59 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 33 citations into it; #430 of 17,773 by trust here, #4,241 by citations
- Cancer Research — 24 citations into it; #35 of 1,780 by trust here, #745 by citations
- Oncology — 22 citations into it
- Cell Biology — 8 citations into it
- Genetics — 6 citations into it
- Neurology — 6 citations into it
- Pulmonary and Respiratory Medicine — 6 citations into it; #89 of 770 by trust here, #324 by citations
- Internal Medicine — 5 citations into it
Whom J. Folkman trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts J. Folkman overall
- Nicola Bellomo
- D. Hanahan
- Rakesh K. Jain
- Y. Fouad
- Robert A. Gatenby
- J. Hornberg
- Ray Zhang
- Wei Wang
- Peter Carmeliet
- N. K. Li
Papers from J. Folkman's perspective
Ordered by how strongly the researchers J. Folkman trusts endorse each paper. Same corpus, a different order for every researcher.
- The anti-angiogenic basis of metronomic chemotherapy (Nature Reviews. Cancer)
- Angiogenesis in life, disease and medicine (Nature)
- Pegaptanib for neovascular age-related macular degeneration. (New England Journal of Medicine)
- Inactivation of the apoptosis effector Apaf-1 in malignant melanoma (Nature)
- Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
- Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis (Proceedings of the National Academy of Sciences of the United States of America)
- Tumor angiogenesis: past, present and the near future. (Carcinogenesis)
- Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (New England Journal of Medicine)
- Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
- A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue (Nature Protocols)
Their papers
- Clinical translation of angiogenesis inhibitors (2002) — 1,601 citations
- Opinion: Angiogenesis: an organizing principle for drug discovery? (2007) — 1,061 citations
- Role of angiogenesis in tumor growth and metastasis. (2002) — 2,896 citations
- Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. (2002) — 814 citations
- Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis (2003) — 700 citations
- Fundamental concepts of the angiogenic process. (2003) — 686 citations
- Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. (2006) — 665 citations
- Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. (2008) — 894 citations
- Angiogenesis: an organizing principle for drug discovery? (2007) — 1,270 citations
- Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. (2000) — 1,658 citations